hydration effects glp-1 receptor agonist therapy 2025 Nutritional priorities to support for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society Ten Top Tips for the

Graphical Abstract Keywords Metabolic dysfunction-associated steatotic liver disease, Glucagon-like peptide-1 receptor agonist, Clinical trial, Treatment, Metabolic dysfunction-associated steatohepatitis, Fibrosis Introduction Nonalcoholic fatty liver disease has been used to describe hepatic steatosis without significant alcohol intake

7 Conclusion and challenges GLP-1RAs have been used to treat T2DM since 2005 and gained approval for weight management in 2014

Levodopa (used for Parkinson disease) effectiveness can be reduced by high-dose B6 unless combined with carbidopa

In gastrointestinal models, it has been associated with supporting the gut lining and cellular balance